GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Global Roundtable GRCU · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

About Global Roundtable

Its shares trade under the ticker GRCU. It has been listed since 30 December 2004. In the fiscal year to 31 December 2012, it reported revenue of $1.9m and net income of $913,100. At that date it held total assets of $37.8m and shareholders' equity of $34.0m.

Green Cures & Botanical Distribution, Inc. develops, produces, and distributes premium hemp based products in the following categories medical, skin care, beauty, fashion and lifestyle goods branded under the Original Hollywood Hemp. The company is headquartered in Woodland Hills, California. The company went IPO on 2004-12-30. The firm offers products that are made in the United States. Its various products are being manufactured of imported materials from the European Continent and Canada. The firm is Web-based and focuses on online retailing and sales. The firm retails and wholesales consumer products in the hemp and botanical industry, including nutritional supplements and sport wellness. The firm retails its products labeled Hemjoba, Green Foods, Hemporium, Green Magic and Green Cures, through its e-commerce sites, allbotanical.com, allcbd.com and other third-party e-commerce sites, as well as physical retail stores in the state of California. The firm focuses on operating in various industries, including nutritional supplement/dietary, health and wellness, and hemp.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Products
Listed since
30 Dec 2004
Employees
20

Leadership

Pay as last reported

  • Rich ThomasChief Executive Officer
  • Mr. Aymar YoboueChief Financial Officer
  • Meki CoxChief Technology Officer
  • Mr. David MoceriChief Marketing Officer
  • Dr. Wendy OseguedaSouth and Central America Chief of Operations, Director, since 2014
  • Dr. Jhasmin SantizoDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Green Cures & Botanical Distribution Inc has a strong brand reputation and recognition in the market.
  • The company has a diverse product portfolio, offering a wide range of botanical and herbal products.
  • Green Cures & Botanical Distribution Inc has a well-established distribution network, allowing for efficient and widespread product availability.

Weaknesses

  • The company heavily relies on third-party suppliers for sourcing its botanical ingredients, which can impact the quality and control over the supply chain.
  • Green Cures & Botanical Distribution Inc has limited capital resources, which may hinder its ability to invest in research and development or expansion initiatives.
  • The company operates in a highly competitive market, facing challenges in differentiating its products from competitors.

Opportunities

  • The growing consumer demand for natural and wellness products provides a significant market opportunity for Green Cures & Botanical Distribution Inc.
  • Expansion into international markets can help the company tap into new customer segments and increase its market share.
  • The legalization of cannabis and CBD products in various regions presents an opportunity for Green Cures & Botanical Distribution Inc to develop and market innovative products in this emerging industry.

Threats

  • Increased government regulations and scrutiny surrounding the cannabis and CBD industry can pose challenges for Green Cures & Botanical Distribution Inc.
  • Intense competition from both established players and new entrants in the market can threaten the company's market position and profitability.
  • Fluctuating raw material prices and availability can impact the company's production costs and profitability.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.